Citadel Advisors’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $73.5K | Buy |
57,009
+11,752
| +26% | +$19.4K | ﹤0.01% | 12223 |
|
|
2025
Q4 | $100K | Sell |
45,257
-171,919
| -79% | -$323K | ﹤0.01% | 11644 |
|
|
2025
Q3 | $352K | Buy |
217,176
+147,904
| +214% | +$309K | ﹤0.01% | 9987 |
|
|
2025
Q2 | $179K | Sell |
69,272
-114,334
| -62% | -$451K | ﹤0.01% | 10782 |
|
|
2025
Q1 | $1.24M | Buy |
183,606
+82,153
| +81% | +$582K | ﹤0.01% | 6497 |
|
|
2024
Q4 | $689K | Buy |
101,453
+99,154
| +4,313% | +$653K | ﹤0.01% | 7869 |
|
|
2024
Q3 | $19.1K | Sell |
2,299
-147,911
| -98% | -$1.07M | ﹤0.01% | 12808 |
|
|
2024
Q2 | $952K | Buy |
150,210
+16,947
| +13% | +$130K | ﹤0.01% | 6683 |
|
|
2024
Q1 | $1.24M | Buy |
133,263
+78,332
| +143% | +$918K | ﹤0.01% | 6499 |
|
|
2023
Q4 | $700K | Buy |
54,931
+51,377
| +1,446% | +$535K | ﹤0.01% | 7397 |
|
|
2023
Q3 | $36.7K | Sell |
3,554
-6,452
| -64% | -$74.7K | ﹤0.01% | 12099 |
|
|
2023
Q2 | $131K | Sell |
10,006
-153,623
| -94% | -$1.88M | ﹤0.01% | 10523 |
|
|
2023
Q1 | $1.83M | Buy |
163,629
+92,810
| +131% | +$916K | ﹤0.01% | 5558 |
|
|
2022
Q4 | $597K | Sell |
70,819
-71,459
| -50% | -$680K | ﹤0.01% | 7869 |
|
|
2022
Q3 | $2.37M | Sell |
142,278
-121,193
| -46% | -$2.23M | ﹤0.01% | 5265 |
|
|
2022
Q2 | $3.88M | Buy |
263,471
+85,518
| +48% | +$1.76M | 0.01% | 4269 |
|
|
2022
Q1 | $4.42M | Buy |
177,953
+82,432
| +86% | +$2.13M | 0.01% | 4423 |
|
|
2021
Q4 | $3.06M | Sell |
95,521
-350,290
| -79% | -$12.8M | ﹤0.01% | 5292 |
|
|
2021
Q3 | $16M | Buy |
445,811
+178,267
| +67% | +$7.01M | 0.02% | 2327 |
|
|
2021
Q2 | $11.8M | Buy |
267,544
+89,558
| +50% | +$3.9M | 0.01% | 2821 |
|
|
2021
Q1 | $8.14M | Buy |
177,986
+48,241
| +37% | +$2.77M | 0.01% | 3298 |
|
|
2020
Q4 | $8.96M | Buy |
+129,745
| New | +$6.35M | 0.01% | 2797 |
|
Other funds holding LUNG
SCM
ECM
VCM
